However, we did not find studies documenting the sHLA-G expression in patients with benign gastric pathologies and more studies are necessary to verify that the early diagnosis of cancer should focus on the detection of preneoplastic lesions that are at risk of progressing to cancer in situ. This evidence concerns the gene HLA-G and cancer.